GSS 2027 · 13–14 May 2027, Barcelona, Spain

Gates Foundation Introduces Catalytic Funding to Advance a New Era of Women-Focused Research and Innovation

8 April 2025

The Gates Foundation has announced a landmark commitment of $2.5 billion through 2030 to accelerate research and development focused exclusively on women’s health. The investment is designed to advance more than 40 innovations across five critical areas that have historically received insufficient funding and scientific attention. With a particular focus on women in low- and middle-income countries, the initiative aims to address unmet medical needs and promote the development of effective, accessible healthcare solutions.

Women’s health research has long faced significant funding gaps, leaving many conditions underdiagnosed, misunderstood, or inadequately treated. Areas such as menstrual disorders, endometriosis, preeclampsia, gestational diabetes, menopause, and pregnancy-related complications continue to require greater scientific attention. A 2021 analysis by McKinsey & Company found that only 1% of healthcare research and innovation funding was directed toward female-specific conditions beyond oncology, highlighting the need for greater investment in research tailored to women’s unique health needs.

The foundation’s commitment will prioritize five major areas: obstetric care and maternal immunization, maternal health and nutrition, gynecological and menstrual health, contraceptive innovation, and sexually transmitted infections. These priorities aim to make pregnancy and childbirth safer, improve maternal and newborn outcomes, strengthen the diagnosis and treatment of gynecological conditions, expand contraceptive choices, and reduce the disproportionate impact of sexually transmitted infections on women.

The investment will also support promising scientific developments, including research into the vaginal microbiome, new treatments for preeclampsia, and non-hormonal contraceptive methods. In addition to research and product development, funding will support data generation and advocacy efforts to help ensure that successful innovations reach the women and girls who need them. The initiative will consider women’s preferences, the challenges of limited-resource healthcare settings, and the need for solutions that can be implemented at scale.

Global Congress on Gender & Sexuality Studies 2027, 13–14 May 2027, Barcelona, Spain.

Contact: maryjones@sciinovhealth.com

NH Collection Barcelona Pódium, Carrer de Bailèn 4, 08010 Barcelona, Spain